We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

Back to rankings

215 hedge funds and large institutions have $3.36B invested in NPS PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 78 increasing their positions, 69 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $2.89B → $3.36B (+$465M)

13% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 69

11% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 44

2% more funds holding

Funds holding: 210 → 215 (+5)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

12% less call options, than puts

Call options by funds: $72.5M | Put options by funds: $82M

Holders
215
Holders Change
+5
Holders Change %
+2.38%
% of All Funds
6.18%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
49
Increased
78
Reduced
69
Closed
44
Calls
$72.5M
Puts
$82M
Net Calls
-$9.5M
Net Calls Change
-$5.8M

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$65.5M
2
Norges Bank
Norges Bank
Norway
+$36.9M
3
Invesco
Invesco
Georgia
+$32.3M
4
VAM
Visium Asset Management
New York
+$29.5M
5
PC
PointState Capital
New York
+$24.6M

Top Sellers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
-$45.8M
2
CWAM
Columbia Wanger Asset Management
Illinois
-$29.9M
3
Franklin Resources
Franklin Resources
California
-$21.8M
4
CCM
Century Capital Management
Massachusetts
-$17.2M
5
TI
Turner Investments
Pennsylvania
-$14.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
GA
151
Geneva Advisors
Illinois
$740K +$647K +22,390 New
CSS
152
Cubist Systematic Strategies
Connecticut
$725K +$634K +21,948 New
US Bancorp
153
US Bancorp
Minnesota
$721K -$42.5K -1,472 -6%
Prudential Financial
154
Prudential Financial
New Jersey
$707K +$309K +10,681 +100%
OAM
155
Oxford Asset Management
United Kingdom
$703K -$3.63M -125,720 -86%
Credit Agricole
156
Credit Agricole
France
$695K +$607K +21,015 New
CA
157
Commerzbank Aktiengesellschaft
Germany
$694K +$607K +21,009 New
PAM
158
Princeton Alpha Management
New Jersey
$678K +$593K +20,527 New
GPCM
159
Granite Point Capital Management
Massachusetts
$661K -$607K -21,000 -51%
NA
160
Navellier & Associates
Nevada
$639K -$9.65K -334 -2%
QIM
161
Quantitative Investment Management
Virginia
$584K -$459K -15,900 -47%
PPA
162
Parametric Portfolio Associates
Washington
$580K -$242K -8,388 -32%
LPL Financial
163
LPL Financial
California
$548K -$9.5K -329 -2%
DCM
164
Daruma Capital Management
New York
$528K +$33.5K +1,158 +8%
ICOA
165
Investment Centers of America
North Dakota
$527K +$460K +15,924 New
Balyasny Asset Management
166
Balyasny Asset Management
Illinois
$519K +$454K +15,700 New
DT
167
Diversified Trust
Tennessee
$507K +$443K +15,335 New
GH
168
GAM Holding
Switzerland
$496K – – –
MAM
169
Martingale Asset Management
Massachusetts
$487K -$196K -6,800 -32%
Comerica Bank
170
Comerica Bank
Texas
$455K -$236K -8,172 -37%
COPPSERS
171
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$416K +$363K +12,580 New
Natixis Advisors
172
Natixis Advisors
Massachusetts
$413K +$58.9K +2,038 +19%
GAM
173
Gotham Asset Management
New York
$400K +$350K +12,104 New
PI
174
Placemark Investments
Illinois
$399K -$68.3K -2,364 -16%
Barclays
175
Barclays
United Kingdom
$363K +$13.5K +466 +4%
5 6
7
8 9

NPSP Hedge Fund Activity: Q2 2014 in Review

215 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q2 2014, worth a combined $3.36B — up 16% from $2.89B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new NPSP positions and 44 closed out — a net gain of 5 holders — while 78 added to existing stakes and 69 trimmed.

The largest buyer was Wells Fargo, adding an estimated $65.5M. The largest seller was RS Investment Management, exiting entirely with an estimated $45.8M sold.

  • 215 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q2 2014, up from 210 in Q1 2014.
  • Funds reported $3.36B of NPS PHARMACEUTICALS INC stock for Q2 2014, up 16% quarter-over-quarter.
  • 49 funds opened new NPS PHARMACEUTICALS INC positions in Q2 2014 and 44 closed out, a net change of +5 holders.
  • The largest NPS PHARMACEUTICALS INC buyer in Q2 2014 was Wells Fargo, an estimated $65.5M added.
  • The largest NPS PHARMACEUTICALS INC seller in Q2 2014 was RS Investment Management, an estimated $45.8M sold.

Based on aggregated 13F filings for Q2 2014.